Management Team

Chris Xu,PhD, MBA
Chairman & CEO

Dr. Chris Xu has served as the Company's Chairman since 2016. He brings over 15 years of leadership experience in the biopharmaceutical industry and has contributed to numerous successful product launches. Dr. Xu's expertise spans several diverse therapeutic areas, including arthritis & inflammation, cardiovascular disease, autoimmunity, oncology and diabetes. He has authored over forty publications and has been recognized by a number of professional societies for his contributions to biomedical research. Dr. Xu received his Ph.D. in immunology from Washington University School of Medicine (St. Louis, USA) and an executive MBA from Emory University (Atlanta, USA).
Haihong Zhu
President & Board Director

Haihong Zhu is the President and a Director of the Board. Ms Zhu brings over 20 years of technical and market experience in stem cell research and global commercial launch. She started her career as a Research Scientist at Harvard Medical School Stem Cell Lab and BioTransplant, Inc. Ms. Zhu graduated from the Shanghai University of Science & Technology with a Bachelor’s in Biology and also studied statistics at Boston University. Ms. Zhu is also a Board Director at ThermoGenesis Holdings Inc (Nasdaq:THMO).
Jeff Cauble
Chief Financial Officer

Jeff Cauble, Chief Financial Officer, brings over 20 years of accounting experience in various financial and managerial roles in the biotechnology, medical device and agricultural industries. Mr. Cauble is a Certified Public Accountant and graduate of the University of Idaho, where he obtained a bachelor’s degree with a dual major in accounting and finance. Mr. Cauble is also a Board Director at ThermoGenesis Holdings Inc (Nasdaq:THMO).
TotipotentRX Cellular Medicine Inc (BVI).
185 Technology Dr Suite 150, Irvine California 92618
Tel : 1 (888) 379-2670